Myriad Genetics Inc (NAS:MYGN)
$ 26.885 0.495 (1.88%) Market Cap: 2.44 Bil Enterprise Value: 2.46 Bil PE Ratio: 0 PB Ratio: 3.30 GF Score: 78/100

Myriad Genetics Inc Virtual Investor Day Transcript

May 04, 2021 / 03:00PM GMT
Release Date Price: $31.62 (+4.01%)
Scott Gleason
Myriad Genetics, Inc. - SVP of IR

Welcome, and thank you for participating in Myriad's 2021 Investor Day. Before we start the event, I wanted to make a few announcements. First, as questions arise during the day, please enter them into the question portal. Please ensure your questions are entered prior to the end of the break period before Q&A, and we will answer as many questions as possible, given time restraints.

Secondly, we'll be making forward-looking statements during this event. Please review the forward-looking statements on the current slide. We'll also be using non-GAAP financial measures. A reconciliation of GAAP to non-GAAP financial results can be found on Myriad's website. With that, let's start the event.

Paul J. Diaz
Myriad Genetics, Inc. - CEO, President & Director

Hi. I'm Paul Diaz, President and CEO of Myriad Genetics. Welcome to everyone joining us for our Virtual Investor Day. I'm coming to you from our new Myriad support center in Salt Lake City. I want to thank my 2,700 teammates for the hard work they

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot